Company intelligence / Profile preview

Robigo

Cambridge, Massachusetts, United Statesrobigo.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

Robigo engineers naturally occurring microbes to serve as environmentally friendly crop protectants. Their technology has shown over a 90% reduction in plant diseases during laboratory testing. The company’s next phase involves demonstrating consistent efficacy in outdoor field environments across multiple crops. Their approach aims to replace toxic chemical pesticides with biological solutions that are safer for soil, pollinators, humans, and the broader environment.

Therapeutic areas: Other
Modalities: Microbial therapyLive biotherapeutic product therapyBiologic
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Robigo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Robigo.

Explore the full profile